Talis Biomedical Corp Quarterly Debt-to-equity in % from Q1 2022 to Q2 2024

Taxonomy & unit: ratio: %
Description: Debt-to-equity (D/E) ratio is used to evaluate a company's financial leverage and is calculated by dividing a company's total liabilities by its shareholder equity.
Summary: Talis Biomedical Corp quarterly Debt-to-equity history and growth rate from Q1 2022 to Q2 2024.
Talis Biomedical Corp Debt-to-equity for the quarter ending June 30, 2024 was 39.5 %, a 43% increase year-over-year.

Debt-to-equity, Quarterly (%)

Debt-to-equity, YoY Quarterly Growth (%)

Period	Value	YoY Chg	Change %	Date
Q2 2024	39.5	+11.9	+43%	Jun 30, 2024
Q1 2024	34.3	+7.43	+27.7%	Mar 31, 2024
Q4 2023	28.3	+4.53	+19%	Dec 31, 2023
Q3 2023	28.5	+9.42	+49.4%	Sep 30, 2023
Q2 2023	27.6	+10.6	+62.2%	Jun 30, 2023
Q1 2023	26.8	+7.64	+39.8%	Mar 31, 2023
Q4 2022	23.8			Dec 31, 2022
Q3 2022	19.1			Sep 30, 2022
Q2 2022	17			Jun 30, 2022
Q1 2022	19.2			Mar 31, 2022

* An asterisk sign (*) next to the value indicates that the value is likely invalid.